Genome Editing of Erythroid Cell Culture Model Systems
Genome editing to introduce specific mutations or to knock out genes in model cell systems has become an efficient platform for research in the fields of molecular biology, genetics, and cell biology. With recent rapid improvements in genome editing techniques, bench-top manipulation of the genome in cell culture has become progressively easier. The application of this knowledge to erythroid cell culture systems now allows the rapid analysis of the downstream effects of virtually any engineered gene disruption or modification in cell systems. Here, we describe a CRISPR/Cas9-based approach to making genomic modifications in erythroid lineage cells which we have successfully used in both murine (MEL) and human (K562) erythroleukaemia immortalized cell lines.
Key wordsGenome editing Genome engineering CRISPR/Cas9 Erythrocyte MEL K562
This work has been supported by funding from the Australian Research Council and the National Health and Medical Research Council to M.C.
- 1.WHO|Sickle-cell disease and other haemoglobin disorders. http://www.who.int/mediacentre/factsheets/fs308/en/. Accessed 12 Dec 2015
- 3.Hemminger J (2012) Identification and reporting of common hemoglobin disorders: a review. Ibnosina J Med Biomed Sci 4:8–10Google Scholar
- 15.Komor AC, Kim YB, Packer MS et al (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 61:5985–5991Google Scholar
- 20.DeWitt M, Magis W, Bray NL, et al (2016) Efficient correction of the sickle mutation in human hematopoietic stem cells using a Cas9 ribonucleoprotein complex. bioRxiv 036236Google Scholar